Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion protein combining a CD19-specific antibody domain with trimerized extracellular domains of human 4-1BBL, designed to induce CD19-specific 4-1BB cross-linking on the surfaces of T and NK cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion protein combining a CD19-specific antibody domain with trimerized extracellular domains of human 4-1BBL, designed to induce CD19-specific 4-1BB cross-linking on the surfaces of T and NK cells [1]. |
Synonyms | RG6076, CD19-4-1BBL, RO7227166 |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Englumafusp alfa RG6076 CD19-4-1BBL RO7227166 inhibitor inhibit